• Health & Medicine

Screening scans 'could cut lung cancer deaths’

Introducing lung screening for people at high risk of lung cancer could reduce deaths from the disease, according to new unpublished research. Introducing lung screening for people at high risk of lung cancer could reduce deaths from the disease, according to new unpublished research.

26 September 2018

Drug combo for advanced skin cancer approved on NHS in England

Patients with a certain type of aggressive skin cancer will now have access to a combination of targeted drugs on the NHS in England. Patients with a certain type of aggressive skin cancer will now have access to a combination of targeted drugs on the NHS in England.

18 September 2018

• Health & Medicine

Pathology staff shortages causing delays to cancer diagnosis, says report

NHS pathology departments are suffering from chronic staff shortages, finds a new report. NHS pathology departments are suffering from chronic staff shortages, finds a new report.

18 September 2018

• Health & Medicine

Number of vapers tops 3 million for first time in Britain

More than 3 million people in Great Britain are now vaping, according to a new report by Action on Smoking and Health (ASH). More than 3 million people in Great Britain are now vaping, according to a new report by Action on Smoking and Health (ASH).

14 September 2018

• Health & Medicine

NHS paying out millions to cover lack of radiologists, says Royal College

The NHS is spending millions on outsourcing to prop up a shortage in radiologists, according to new figures from the Royal College of Radiologists (RCR). The NHS is spending millions on outsourcing to prop up a shortage in radiologists, according to new figures from the Royal College of Radiologists (RCR).

6 September 2018

• Health & Medicine

Engineered cell therapy given initial ‘no’ for NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England. A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England.

30 August 2018

• Health & Medicine

Obesity at record high in children aged 10-11 years

More ten to eleven-year-olds in England are seriously obese than has ever been recorded, according to new research by Public Heath England. More ten to eleven-year-olds in England are seriously obese than has ever been recorded, according to new research by Public Heath England.

25 July 2018

• Health & Medicine

Brain tumour funding boost following death of Tessa Jowell

The Government has announced it will double a recent funding boost for brain tumour research following the death of Dame Tessa Jowell. The Government has announced it will double a recent funding boost for brain tumour research following the death of Dame Tessa Jowell.

14 May 2018

• Health & Medicine

London Mayor plans junk food ad ban on public transport

Mayor of London Sadiq Khan has revealed plans to impose a ban on junk food advertising on public transport, in a bid to tackle childhood obesity. Mayor of London Sadiq Khan has revealed plans to impose a ban on junk food advertising on public transport, in a bid to tackle childhood obesity.

11 May 2018

• Health & Medicine

Choice of lung cancer treatment could be affecting survival

Variations in lung cancer treatment may be limiting survival in England, according to a new study. Variations in lung cancer treatment may be limiting survival in England, according to a new study.

8 March 2018

• Health & Medicine

Food industry told to cut calories to tackle obesity

A plan to lower obesity levels by reducing calories in many foods has been announced. A plan to lower obesity levels by reducing calories in many foods has been announced.

6 March 2018

• Science & Technology

Aggressive brain tumours carry potential target for engineered immune cells

A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified. A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified.

1 March 2018